What are the guidelines for starting norepinephrine or dopamine in sepsis patients in the ward and in the intensive care unit?

Vasopressor Guidelines for Sepsis: Ward vs ICU

Norepinephrine is the first-line vasopressor for septic shock and should be started when mean arterial pressure (MAP) remains <65 mmHg despite adequate fluid resuscitation (minimum 30 mL/kg crystalloids), regardless of whether the patient is in the ward or ICU 1.

When to Start Vasopressors

Fluid Resuscitation First

• Administer at least 30 mL/kg of crystalloids for suspected hypovolemia 1
• Continue fluid challenges as long as hemodynamic parameters improve (based on dynamic markers like pulse pressure variation or static markers like arterial pressure, heart rate) 1
• Do not delay vasopressors if MAP target is not achieved after adequate fluid loading

Initiation Criteria

• Target MAP: ≥65 mmHg (higher targets may be appropriate in patients with chronic hypertension) 1
• Start vasopressors when hypotension persists despite fluid resuscitation
• Early norepinephrine administration (within 1 hour, particularly when lactate ≤3 mmol/L) reduces mortality, decreases total fluid volume, and achieves MAP targets faster 2

First-Line Agent: Norepinephrine

Norepinephrine is strongly recommended over dopamine (strong recommendation, moderate quality evidence) 1. The evidence is compelling:

• Norepinephrine reduces all-cause mortality by 11% compared to dopamine (absolute risk reduction, number needed to treat = 9) 3
• Significantly fewer cardiac arrhythmias and major adverse events compared to dopamine 3, 4
• Superior hemodynamic profile with better central venous pressure, urinary output, and lower lactate levels 3

Dopamine: Limited Role Only

Dopamine should only be used as an alternative vasopressor in highly selected patients (weak recommendation, low quality evidence) 1:

Specific Indications for Dopamine

• Patients with low risk of tachyarrhythmias AND
• Absolute or relative bradycardia 1

Critical Warnings About Dopamine

• Do NOT use low-dose dopamine for renal protection (strong recommendation, high quality evidence) 1
• Associated with increased arrhythmic events 5
• In elderly patients with pre-existing heart failure, dopamine reduces ICU/hospital length of stay but increases new-onset arrhythmias 6

Ward vs ICU Considerations

Ward Setting

• Patients requiring vasopressors should ideally be in an ICU setting where continuous monitoring and arterial line placement are available
• If vasopressors must be started in the ward due to resource constraints or patient deterioration:
  • Use large veins (antecubital fossa preferred over hand/ankle veins) 7
  • Mandatory use of infusion pump (preferably volumetric pump, NOT gravity drip) 7
  • Continuous monitoring of blood pressure
  • Immediate transfer to ICU should be arranged

ICU Setting

• Place arterial catheter as soon as practical when vasopressors are required (weak recommendation, very low quality evidence) 1
• Allows precise blood pressure monitoring and frequent blood gas sampling
• Facilitates titration to hemodynamic targets

Dosing Algorithm

Norepinephrine Dosing

1. Start at 2-5 mcg/kg/min for patients likely to respond to modest increments 7
2. For more seriously ill patients, start at 5 mcg/kg/min 7
3. Increase gradually in 5-10 mcg/kg/min increments up to 20-50 mcg/kg/min as needed 7
4. >50% of patients are maintained on <20 mcg/kg/min 7
5. Critical threshold: Doses >1.13 mcg/kg/min predict higher mortality (sensitivity 67%, specificity 80%) 8

When Norepinephrine is Insufficient

If MAP target not achieved with norepinephrine alone:

Add vasopressin 0.03 units/min (weak recommendation, moderate quality evidence) 1 OR add epinephrine (weak recommendation, low quality evidence) 1

Important caveat: In elderly patients with pre-existing heart failure, norepinephrine combined with vasopressin decreases 5-year survival and increases malignant arrhythmias 6. In this specific population, consider increasing norepinephrine dose or adding epinephrine instead.

Monitoring and Adjustment

Signs to Reduce or Stop Vasopressors

• Diminishing urine output despite adequate MAP 7
• Increasing tachycardia 7
• Development of new dysrhythmias 7
• Disproportionate rise in diastolic pressure (marked decrease in pulse pressure) 7

Discontinuation

• Gradually decrease dose while expanding blood volume with IV fluids 7
• Prevents marked hypotension upon abrupt cessation 7

Common Pitfalls to Avoid

1. Delaying vasopressor initiation: Profound and durable hypotension independently increases mortality 9. Early norepinephrine (within 1 hour) improves outcomes 2
2. Using dopamine as first-line: This increases arrhythmias and mortality compared to norepinephrine 5, 3
3. Using low-dose dopamine for "renal protection": This is ineffective and not recommended 1
4. Inadequate monitoring: Vasopressors require continuous hemodynamic monitoring and preferably arterial line placement 1
5. Extravasation: Use large veins and monitor infusion sites continuously; extravasation causes tissue necrosis 7
6. Gravity-controlled infusions: Always use infusion pumps for vasopressor administration 7